Introduction:
In 2026, the global pharmaceutical industry continues to see a rise in demand for specialty drugs, leading to an increase in the availability of patient assistance programs. As the market for specialty drugs grows, pharmaceutical companies are investing more in patient assistance programs to ensure access to these vital medications. According to recent reports, the specialty drug market is projected to reach $568 billion by 2026.
Top 10 Global Specialty Drug Patient Assistance Programs 2026:
1. Pfizer Patient Assistance Program – With a market share of 15%, Pfizer’s patient assistance program offers support to patients in need of specialty medications, particularly in the areas of oncology and rare diseases.
2. Novartis Patient Assistance Foundation – Novartis’s patient assistance program provides assistance to over 100,000 patients annually, with a focus on specialty drugs for conditions such as multiple sclerosis and psoriasis.
3. Johnson & Johnson Patient Assistance Foundation – Johnson & Johnson’s patient assistance program offers support for specialty drugs in areas such as immunology and infectious diseases, serving a wide range of patients worldwide.
4. AbbVie Patient Assistance Program – AbbVie’s patient assistance program focuses on specialty drugs for conditions such as rheumatoid arthritis and Crohn’s disease, providing financial assistance to eligible patients.
5. Roche Patient Foundation – Roche’s patient assistance program supports patients in need of specialty medications, particularly in the areas of oncology and hematology, with a market share of 10%.
6. Merck Patient Assistance Program – Merck’s patient assistance program offers support for specialty drugs in areas such as diabetes and cardiovascular diseases, serving a diverse patient population globally.
7. Amgen Safety Net Foundation – Amgen’s patient assistance program provides assistance to patients in need of specialty medications for conditions such as osteoporosis and cancer, with a market share of 8%.
8. Bristol Myers Squibb Patient Assistance Foundation – Bristol Myers Squibb’s patient assistance program focuses on specialty drugs for conditions such as HIV/AIDS and leukemia, offering financial support to eligible patients worldwide.
9. AstraZeneca Access 360 – AstraZeneca’s patient assistance program offers support for specialty drugs in areas such as respiratory diseases and oncology, serving patients in over 100 countries.
10. Gilead Advancing Access – Gilead’s patient assistance program provides assistance to patients in need of specialty medications for conditions such as hepatitis C and HIV/AIDS, with a market share of 7%.
Insights:
As the demand for specialty drugs continues to grow, patient assistance programs play a crucial role in ensuring access to these life-saving medications. Pharmaceutical companies are increasingly investing in these programs to support patients in need, with a focus on providing financial assistance and resources. In 2026, the global market for specialty drugs is expected to see further growth, with an estimated 20% increase in market size. This trend highlights the importance of patient assistance programs in the pharmaceutical industry and the ongoing commitment of companies to support patients worldwide.
Related Analysis: View Previous Industry Report
